About Accu-Chek/mySugr (UK/IE)
With nearly 50 years of experience, Roche is dedicated to helping people with diabetes think less about their daily routines so they can experience true relief, day and night. Through our Accu-Chek® and mySugr® brands, we offer an integrated ecosystem of solutions, from traditional blood glucose monitoring to predictive continuous glucose monitoring (CGM) technology and digital data management, supporting people with diabetes and healthcare providers, no matter where they are on their diabetes journey.
Learn more: accu-chek.co.uk/hcp
About embecta™
Empowered by 100 years of innovation, our mission at embecta™ is to develop and provide solutions that make life better for people living with diabetes. embecta™ is a leading producer of diabetes injection devices, manufacturing approximately 8 billion devices annually for an estimated 30 million PWD. Through its approximately 2,000 employees around the world, embecta™ is working to advance the standard of care in insulin delivery through strong community partnerships, innovative technology and comprehensive care resources.
Learn more: About embecta™ – Discover Our Mission & History
About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the centre of our ambitions.
Learn more: www.sanofi.co.uk